Authors


Sarah Derby, MBChB

Latest:

Advanced Penile Cancer Presenting With Renal Failure

“MK,” a man aged 67 years, presented with fatigue and nausea to his primary care physician. CT staging scans confirmed the primary tumor and a suspicious left 1.2-cm inguinal lymph node but no distant metastases. MRI of the pelvis revealed complete replacement of the penis with tumor as well as invasion into the scrotum and bilateral groin soft tissue; additionally, early pubic bone invasion was present, with left groin lymphadenopathy. Biopsy verified squamous cell carcinoma of the penis, and discussion with the multidisciplinary team uroradiologist confirmed bony invasion.


Zev A. Wainberg, MD

Latest:

Starting at the Front Line in Metastatic Pancreatic Cancer As New Options Emerge, How Do You Select and Sequence?

Experts in gastrointestinal cancer focus on frontline therapy options for patients with pancreatic cancer.


Ilene Ceil Weitz, MD

Latest:

3 Things You Should Know About Hemolytic Anemias

Hemolytic anemias are a collection of rare but severe diseases including paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome.


Nour Abdallah, MD

Latest:

AI-Based Model May Guide Decision-Making in Kidney Cancer Based on CT, EGFR

Data demonstrate the feasibility of automated glomerular filtration rate prediction to decide between partial nephrectomy and radical nephrectomy in kidney cancer, according to an expert from the Cleveland Clinic.


Fatma Betül Ayrak, MD

Latest:

Spinal ATRT and Radiotherapy Case Report in an Adult Man

A rare case of spinal atypical teratoid/rhabdoid tumor is presented in an adult man after presenting with neck pain and bilateral upper extremity paralysis.


Yichen Lu, MD

Latest:

Profilin 1 Protein and Its Implications for Cancers

Profilin 1, or PFN1, is a key actin-binding protein that is involved in various cellular activities, such as cell motility, survival, and membrane trafficking. By summarizing the functions of PFN1 in cancer, investigators hope to better understand the mechanisms of PFN1 in cancer progression.


Steven Chen, MD, MBA

Latest:

The QOL Impact of Lymphedema After Breast Cancer

Lymphedema is a common adverse effect and may negatively impact a patient’s body image.


Gi-Ming Wang, MS

Latest:

The Negative Impact of the COVID-19 Pandemic on Oncology Care at an Academic Cancer Referral Center

COVID-19 created unexpected delays in oncologic treatment. This study sought to assess the volume of missed cancer-related services due to the pandemic.



Michael Ganio, PharmD, MS, BCPS, FASHP

Latest:

Navigating the Impact of Chemotherapy Shortages on Cancer Care and Finances

Pharmaceutical, gynecologic oncology, and physician perspectives shed light on potentially mitigating the ongoing carboplatin and cisplatin shortages’ effects on cancer care in the United States.



Srikala Sridhar, MD, MSc, FRCPC

Latest:

The Future of Metastatic Urothelial Carcinoma Management

Closing out their review of metastatic urothelial carcinoma management, panelists share what they most look forward to in the evolving treatment landscape.




Guadalupe Elizabeth Trejo-Durán, MD, MSc

Latest:

The Role of Postmastectomy Radiotherapy in Locally Advanced Breast Cancer After Pathological Complete Response to Neoadjuvant Chemotherapy

Experts examine the case of a previously healthy woman, aged 32 years, presented to the oncology clinic with a 6-month history of left-breast tumor, mastalgia, and swollen axillary nodes.



Niloufer Khan, MD, MS

Latest:

Current Treatment of Peripheral T-cell Lymphoma

This review article written by Robert Stuver, MD, et al, reviews current and available treatments for peripheral T-cell lymphoma.


Nabil Rizk

Latest:

Lung Cancer Treatment & Screening

Dr. Nabil Rizk, Chief of Thoracic Surgery on increasing participation and accessibility of lung cancer screening.


Hakan Kaya, MD

Latest:

Selinexor: Clinical Pearls for Current and Future Use in R/R MM

Dr Joseph Mikhael and Dr Hakan Kaya provide advice for community oncologists who use selinexor and discuss the future of selinexor in patients with R/R MM.


Rachel A. Greenup, MD, MPH

Latest:

Reducing Post-Mastectomy Disparities in Breast Cancer Minority Populations

A study evaluating disparities in breast reconstructive surgery sought to assess the impact of culture, race, and ethnicity in minority groups.


Joshua J. Meeks, MD, PhD, BS

Latest:

Expert Discusses Strategies for Managing BCG Shortage in Bladder Cancer

Considering cystectomy in patients with bladder cancer may help with managing the shortage of Bacillus Calmette-Guerin, according to Joshua J. Meeks, MD, PhD, BS.



Loren Winters

Latest:

Medical World News® After Hours: Nurse Practitioner Loren Winters Discusses Staying Balanced With Yoga and Ayurveda

During an After Hours segment of Medical World News®, Loren Winters, MSN, ANP-BC, OCN, spoke about her passion for health and wellness, expressed through yoga instruction and Ayurvedic health coaching.


Nazy Zomorodian, NP

Latest:

Enfortumab/Pembrolizumab Dosing Schedule ‘Groundbreaking’ in Urothelial Cancer

Nazy Zomorodian, NP, spoke with CancerNetwork® about the unique dosing schedule of enfortumab vedotin plus pembrolizumab following its accelerated approval by the FDA in advanced/metastatic urothelial cancer.


Hanqiong Zhou, MD

Latest:

Ocular Toxicities of MEK Inhibitors in Patients With Cancer: A Systematic Review and Meta-analysis

Jing Han, MD, and colleagues examine the prevalence and characteristics of ocular toxicities associated with MEK inhibition.




Dori Beeler, PhD

Latest:

Oncology Peer Review On-The-Go: Cancer-Related Fatigue Outcome Measures in Integrative Oncology

Authors Dori Beeler, PhD; Shelley Wang, MD, MPH; and Viraj A. Master, MD, PhD, spoke with CancerNetwork® about a review article on cancer-related fatigue published in the journal ONCOLOGY®.